Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
43.1 GBX | -0.35% | -2.71% | -63.00% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
05-01 | Avacta picks Christina Coughlin to replace long-serving CEO | AN |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
195M | - | |||||
115B | ||||||
106B | ||||||
21.96B | - | |||||
21.87B | - | |||||
19.21B |
- Stock Market
- Equities
- AVCT Stock
- Charts Avacta Group Plc
- Sector Chart